What question did this study set out to answer?

To summarize recent advances in the first-line treatment of metastatic colorectal cancer (mCRC).

An Update on Treatment Advances for the First-Line Therapy of Metastatic Colorectal Cancer

View Full Paper

Ask AI

Bookmark

To summarize recent advances in the first-line treatment of metastatic colorectal cancer (mCRC).
Review of treatment evolution over the last 10 years.
Analysis of combination regimens such as FOLFOX and FOLFIRI.
Discussion of biologic agents targeting VEGF and EGFR.
Combination therapies involving 5-FU with oxaliplatin or irinotecan improve overall response rates and survival.
Capecitabine shown to be as effective as infusional 5-FU when combined with oxaliplatin.
Biologics like bevacizumab and cetuximab enhance efficacy when paired with chemotherapy for mCRC.

No takes yet. Share an insight, caveat, or question.

This update reviews treatment advancements in metastatic colorectal cancer, suggesting improved outcomes with combination therapies.

Lee et al. (2007) studied this question.

View Full Paper

Ask AI

Bookmark